Two new studies that compared antipsychotics seek to fill that gap. The first, which Hamina led, measured the efficacy of ...

INVEGA HAFYERA contains the active ingredient paliperidone palmitate. INVEGA HAFYERA is used to treat schizophrenia in adults (18 years of age and older). For more information, see Section 1.

Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulator to manufacture its generic version of Paliperidone extended-release tablets, used to treat ...

Ahmedabad: Zydus Lifesciences Limited has announced that it has received in principle acceptability from World Health ...

Some second-generation antipsychotics, including paliperidone and sertindole, showed slightly better cognitive outcomes but without significant benefits over placebo. Antipsychotics grouped by ...

Since they were not qualified to administer his now three-day overdue paliperidone injection, they provided him with a safety plan, advising him to take olanzapine overnight and to avoid alcohol ...

TCS reported a net profit of Rs 11,909 crore for Q2FY25, up 5 per cent year-on-year but down 1.08 per cent sequentially: stocks to watch ...

A key rival could be Johnson & Johnson's recently-approved Invega Hafyera (paliperidone), which only needs to be administered twice-yearly, as well as J&J's older monthly and three-monthly ...

Second place was Johnson & Johnson’s schizophrenia treatment Invega Sustenna/Invega Trinza (paliperidone), with a 6.8% increase in the list price – and 10.7% net – which added $203 million ...

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg (USRLD: ...

Ahmedabad: Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as "Zydus") has received final approval from the United States Food and Drug Administration (USFDA) ...